Your search returned 442 results.

Results
	421.	Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms. [electronic resource] by Serels, Scott R Toglia, Marc R Forero-Schwanhaeuser, Sergio He, Weizhong Producer: 20110209 In: Current medical research and opinion vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	422.	Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE). [electronic resource] by Drake, Marcus J MacDiarmid, Scott Chapple, Christopher R Esen, Adil Athanasiou, Stavros Cambronero Santos, Javier Mitcheson, David Herschorn, Sender Siddiqui, Emad Huang, Moses Stoelzel, Matthias Producer: 20180716 In: International journal of clinical practice vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	423.	The emergence of new drugs for overactive bladder. [electronic resource] by McCrery, Rebecca J Smith, Phillip P Appell, Rodney A Producer: 20061114 In: Expert opinion on emerging drugs vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	424.	Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia. [electronic resource] by Nazir, Jameel Heemstra, Lars van Engen, Anke Hakimi, Zalmai Ivanescu, Cristina Producer: 20160418 In: BMC urology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	425.	Resveratrol improves urinary dysfunction in rats with chronic prostatitis and suppresses the activity of the stem cell factor/c-Kit signaling pathway. [electronic resource] by Yu, Yang Jiang, Jiang He, Yi Wang, Wei Shen, Chen Yang, Bo Producer: 20180611 In: Molecular medicine reports vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	426.	Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study). [electronic resource] by Herschorn, Sender Chapple, Christopher R Abrams, Paul Arlandis, Salvador Mitcheson, David Lee, Kyu-Sung Ridder, Arwin Stoelzel, Matthias Paireddy, Asha van Maanen, Rob Robinson, Dudley Producer: 20171213 In: BJU international vol. 120 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	427.	Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. [electronic resource] by Zinner, Norman Noe, Les Rasouliyan, Lawrence Marshall, Thomas Seifeldin, Raafat Producer: 20080819 In: Current medical research and opinion vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	428.	A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial. [electronic resource] by Park, Jinsung Yoo, Changhee Han, Deok Hyun Shin, Dong Wook Producer: 20160825 In: World journal of urology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	429.	Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study. [electronic resource] by Wagg, Adrian Dale, Mark Tretter, Reiner Stow, Bridget Compion, Gerhard Producer: 20140204 In: European urology vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	430.	Decrease of risk of developing symptoms of OAB in elderly men and women treated with loop diuretic for hypertensive disease using solifenacin. [electronic resource] by Kosilov, Kirill V Loparev, Sergay A Ivanovskaya, Marina A Kosilova, Liliya V Producer: 20151026 In: Current aging science vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	431.	Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom. [electronic resource] by Hart, Warren Mark Abrams, Paul Munro, Vicki Retsa, Peny Nazir, Jameel Producer: 20140428 In: Journal of medical economics vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	432.	Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension. [electronic resource] by Drake, Marcus J Chapple, Christopher Sokol, Roman Oelke, Matthias Traudtner, Klaudia Klaver, Monique Drogendijk, Ted Van Kerrebroeck, Philip Producer: 20151217 In: European urology vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	433.	Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis. [electronic resource] by Yoshida, Akira Kageyama, Aiko Fujino, Tomomi Nozawa, Yoshihisa Yamada, Shizuo Producer: 20101115 In: Urology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	434.	Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected]. [electronic resource] by MacDiarmid, Scott Al-Shukri, Salman Barkin, Jack Fianu-Jonasson, Aino Grise, Philippe Herschorn, Sender Saleem, Tahir Huang, Moses Siddiqui, Emad Stölzel, Matthias Hemsted, Claire Nazir, Jameel Hakimi, Zalmai Drake, Marcus J Producer: 20180806 In: The Journal of urology vol. 196 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	435.	M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. [electronic resource] by Ikeda, Ken Kobayashi, Seiji Suzuki, Mami Miyata, Keiji Takeuchi, Makoto Yamada, Toshimitsu Honda, Kazuo Producer: 20030124 In: Naunyn-Schmiedeberg's archives of pharmacology vol. 366 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	436.	A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. [electronic resource] by Callegari, Ernesto Malhotra, Bimal Bungay, Peter J Webster, Rob Fenner, Katherine S Kempshall, Sarah LaPerle, Jennifer L Michel, Martin C Kay, Gary G Producer: 20120102 In: British journal of clinical pharmacology vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	437.	Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN). [electronic resource] by Van Kerrebroeck, Philip Haab, François Angulo, Javier C Vik, Viktor Katona, Ferenc Garcia-Hernandez, Alberto Klaver, Monique Traudtner, Klaudia Oelke, Matthias Producer: 20140331 In: European urology vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	438.	Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. [electronic resource] by Ohtake, Akiyoshi Saitoh, Chikashi Yuyama, Hironori Ukai, Masashi Okutsu, Hiroko Noguchi, Yukiko Hatanaka, Toshiki Suzuki, Masanori Sato, Shuichi Sasamata, Masao Miyata, Keiji Producer: 20070313 In: Biological & pharmaceutical bulletin vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	439.	Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study). [electronic resource] by Yamaguchi, Osamu Kakizaki, Hidehiro Homma, Yukio Igawa, Yasuhiko Takeda, Masayuki Nishizawa, Osamu Gotoh, Momokazu Yoshida, Masaki Yokoyama, Osamu Seki, Narihito Okitsu, Akira Hamada, Takuya Kobayashi, Akiko Kuroishi, Kentaro Producer: 20200615 In: International journal of urology : official journal of the Japanese Urological Association vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	440.	American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA). [electronic resource] by Hodgkinson, L Producer: 20171103 In: Drugs of today (Barcelona, Spain : 1998) vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 442 results.